Updated Jul 16, 2026
MARTELL RON is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $100K.
Ron Martell is the President and CEO of Jasper Therapeutics, Inc., a clinical-stage biotechnology company focused on hematopoietic stem cell therapy. He has held leadership roles within the company, contributing to its mission of developing safer and more effective treatments.
| Role | President, CEO and Director, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-22 | JSPR | Jasper Therapeutics, Inc. | P — Open-market purchase | 41.0K | $2.43 | $100K |
Ron Martell is the President and CEO of Jasper Therapeutics, Inc., a clinical-stage biotechnology company focused on hematopoietic stem cell therapy. He has held leadership roles within the company, contributing to its mission of developing safer and more effective treatments.…
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MARTELL RON profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.